Trademark: 97225216
Word
MEDABLE REMOTE ECONSENT
Status Date
Wednesday, January 24, 2024
Filing Date
Tuesday, January 18, 2022
Published for Opposition
Tuesday, November 29, 2022
9 Downloadable software for operating and managing clinical trials by third parties; downloadable software for providing telemedicine services; downloadable software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials
42 Software as a service (SaaS) services featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing telemedicine services; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing telemedicine services; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Extension 2 Granted
Jan 24, 2024
Sou Extension 2 Filed
Jan 24, 2024
Sou Teas Extension Received
Jul 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2023
Sou Extension 1 Granted
Jul 24, 2023
Sou Extension 1 Filed
Jul 24, 2023
Sou Teas Extension Received
Jan 24, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2022
Published For Opposition
Nov 9, 2022
Notification Of Notice Of Publication E-Mailed
Oct 26, 2022
Approved For Pub - Principal Register
Oct 26, 2022
Examiner's Amendment Entered
Oct 26, 2022
Notification Of Examiners Amendment E-Mailed
Oct 26, 2022
Examiners Amendment E-Mailed
Oct 26, 2022
Examiners Amendment -Written
Oct 26, 2022
Assigned To Examiner
Jan 24, 2022
New Application Office Supplied Data Entered
Jan 21, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
